Prefrontal cortex-specific Dcc deletion induces schizophrenia-related behavioral phenotypes and fail to be rescued by olanzapine treatment.

[1]  J. Qian,et al.  Cyclophilin D-mediated angiotensin II-induced NADPH oxidase 4 activation in endothelial mitochondrial dysfunction that can be rescued by gallic acid. , 2022, European journal of pharmacology.

[2]  Lin He,et al.  miR143-3p–Mediated NRG-1–Dependent Mitochondrial Dysfunction Contributes to Olanzapine Resistance in Refractory Schizophrenia , 2022, Biological Psychiatry.

[3]  R. Brownstone,et al.  Heterozygous Dcc Mutant Mice Have a Subtle Locomotor Phenotype , 2022, eNeuro.

[4]  I. Sommer,et al.  The dual hit hypothesis of schizophrenia: Evidence from animal models , 2021, Neuroscience & Biobehavioral Reviews.

[5]  Feng Liu,et al.  Increased Homotopic Connectivity in the Prefrontal Cortex Modulated by Olanzapine Predicts Therapeutic Efficacy in Patients with Schizophrenia , 2021, Neural plasticity.

[6]  Z. Yao,et al.  Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization , 2021, Nature Communications.

[7]  Kohji Sato.  Why is prepulse inhibition disrupted in schizophrenia? , 2020, Medical hypotheses.

[8]  Meina Guo,et al.  Adult conditional knockout of PGC-1α in GABAergic neurons causes exaggerated startle reactivity, impaired short-term habituation and hyperactivity , 2020, Brain Research Bulletin.

[9]  Shao J Liu,et al.  No DCX-positive neurogenesis in the cerebral cortex of the adult primate , 2020, Neural regeneration research.

[10]  Meiyu Wu,et al.  A pilot study on searching for peri-nuclear NeuN-positive cells , 2020, PeerJ.

[11]  E. S. Ruthazer,et al.  Pre- and post-synaptic roles for DCC in memory consolidation in the adult mouse hippocampus , 2019, Molecular Brain.

[12]  F. Bustos,et al.  PSD95 regulates morphological development of adult-born granule neurons in the mouse hippocampus , 2019, Journal of Chemical Neuroanatomy.

[13]  H. Ahsan,et al.  Asiatic Acid Protects Dopaminergic Neurons from Neuroinflammation by Suppressing Mitochondrial ROS Production , 2019, Biomolecules & therapeutics.

[14]  P. McGuire,et al.  Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis , 2019, JAMA psychiatry.

[15]  Qiu-Yun Chen,et al.  Smart mitochondrial‐targeted cancer therapy: Subcellular distribution, selective TrxR2 inhibition accompany with declined antioxidant capacity , 2019, International journal of pharmaceutics.

[16]  Hunna J. Watson,et al.  Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders , 2019, bioRxiv.

[17]  E. S. Ruthazer,et al.  Activity-Dependent Netrin-1 Secretion Drives Synaptic Insertion of GluA1-Containing AMPA Receptors in the Hippocampus. , 2018, Cell reports.

[18]  G. Breen,et al.  Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort , 2018, Translational Psychiatry.

[19]  R. Kahn,et al.  Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) , 2018, Molecular Psychiatry.

[20]  Anders M. Dale,et al.  Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms , 2018, Schizophrenia bulletin.

[21]  Qiu-Yun Chen,et al.  Mitochondrial dysfunction is responsible for fatty acid synthase inhibition-induced apoptosis in breast cancer cells by PdpaMn. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Wenjun Gao,et al.  PSD95: A synaptic protein implicated in schizophrenia or autism? , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  Chi Ma,et al.  Netrin-1 promotes glioma growth by activating NF-κB via UNC5A , 2017, Scientific Reports.

[24]  A. Tanskanen,et al.  Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia , 2017, JAMA psychiatry.

[25]  Jing Gao,et al.  Desensitizing Mitochondrial Permeability Transition by ERK-Cyclophilin D Axis Contributes to the Neuroprotective Effect of Gallic Acid against Cerebral Ischemia/Reperfusion Injury , 2017, Front. Pharmacol..

[26]  E. Nestler,et al.  DCC Confers Susceptibility to Depression-like Behaviors in Humans and Mice and Is Regulated by miR-218 , 2017, Biological Psychiatry.

[27]  A. Vita,et al.  Schizophrenia , 2016, The Lancet.

[28]  H. Lei,et al.  NMDA receptor antagonism by repetitive MK801 administration induces schizophrenia-like structural changes in the rat brain as revealed by voxel-based morphometry and diffusion tensor imaging , 2016, Neuroscience.

[29]  F. Turkheimer,et al.  Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. , 2016, Schizophrenia bulletin.

[30]  Peng Yan,et al.  An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia , 2016, Journal of Molecular Neuroscience.

[31]  M. Buckwalter,et al.  Glial Fibrillary Acidic Protein-Expressing Glia in the Mouse Lung , 2015, ASN neuro.

[32]  J. Sato,et al.  Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia , 2013, Schizophrenia Research.

[33]  E. S. Ruthazer,et al.  DCC expression by neurons regulates synaptic plasticity in the adult brain. , 2013, Cell reports.

[34]  Daniel L. Koller,et al.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction , 2012, Molecular Psychiatry.

[35]  D. Rao,et al.  siRNA vs. shRNA: similarities and differences. , 2009, Advanced drug delivery reviews.

[36]  H. Gunduz-Bruce,et al.  The acute effects of NMDA antagonism: From the rodent to the human brain , 2009, Brain Research Reviews.

[37]  Ferran Sanz,et al.  Multi‐Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New β2 Adrenergic Receptor Template , 2008, ChemMedChem.

[38]  P. Roussos,et al.  Improvement of Prepulse Inhibition and Executive Function by the COMT Inhibitor Tolcapone Depends on COMT Val158Met Polymorphism , 2008, Neuropsychopharmacology.

[39]  Yudong D. He,et al.  Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice , 2006, Nucleic acids research.

[40]  Kyonsoo Hong,et al.  Activation of FAK and Src are receptor-proximal events required for netrin signaling , 2004, Nature Neuroscience.

[41]  M. Sheng,et al.  Postsynaptic Signaling and Plasticity Mechanisms , 2002, Science.

[42]  O. Wolkowitz,et al.  Benzodiazepines in Schizophrenia: Prefrontal Cortex Atrophy Predicts Clinical Response to Alprazolam Augmentation , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[43]  D. Javitt,et al.  Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.

[44]  R. Malinow,et al.  Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. , 2000, Science.

[45]  C. Stephenson,et al.  Psychopharmacology of olanzapine , 1999, British Journal of Psychiatry.

[46]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[47]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[48]  Qiang Xu,et al.  Andrographolide alleviates parkinsonism in MPTP-PD mice via targeting DRP1-mediated mitochondrial fission. , 2019, British journal of pharmacology.

[49]  Qiang Xu,et al.  Andrographolide sulfonate improves Alzheimer-associated phenotypes and mitochondrial dysfunction in APP/PS1 transgenic mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  W. Honer,et al.  Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats. , 2014, The international journal of neuropsychopharmacology.

[51]  Jürgen Götz,et al.  Primary support cultures of hippocampal and substantia nigra neurons , 2008, Nature Protocols.

[52]  Pavel Osten,et al.  Stereotaxic gene delivery in the rodent brain , 2007, Nature Protocols.

[53]  R. Malenka,et al.  AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.